Spartanburg Medical Research
Spartanburg, South Carolina, 29303, United States
NCT Number: NCT02535442
The objective of this study is to evaluate the microbial consortia and the host inflammatory factors present in the nasal passages of patients during upper respiratory symptomology and when healthy using culture and molecular analysis techniques.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Spartanburg, South Carolina, 29303, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Change from baseline compared to Day 21
Kimberly-Clark Corporation
Industry
An Exploratory Study to Evaluate the Microbial Consortia and the Host Inflammatory Factors Present in the Nasal Passages of Patients During Upper Respiratory Symptomology and When Healthy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06724185
Common Cold, Immunity
Taichung, Taiwan
View Trial DetailsNCT00448981
Common Cold, Infections
New York, United States
View Trial DetailsNCT06716645
Common Cold, Cough
New York, United States
View Trial DetailsNCT06278324
Acute Respiratory Tract Infection, COVID-19
Dijon, Burgundy, France
View Trial Details